Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brachytherapy in the elderly.

P Montemaggi1, P Guerrieri

  • 1U.O. of Radiotherapy, Regional Cancer Center, Ospedale Mariano Santo, 87100 Cosenza, Italy. montemaggi@antares.it

Critical Reviews in Oncology/Hematology
|February 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Will malaria be the eternal scourge of Algeria?].

Revue generale de medecine & de chirurgie de l'Union francaise·2014
Same author

Three-dimensional conformal radiotherapy in localized carcinoma of prostate: preliminary reports of toxicity in dose-escalation treatment.

Urologia·2010
Same author

Overexpressed transglutaminase 5 triggers cell death.

Amino acids·2004
Same author

Transglutaminase 5 is acetylated at the N-terminal end.

Amino acids·2004
Same author

Nitric oxide can inhibit apoptosis or switch it into necrosis.

Cellular and molecular life sciences : CMLS·2000
Same author

Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.

Clinical cancer research : an official journal of the American Association for Cancer Research·2000
Same journal

Neoadjuvant Immunotherapy in Melanoma: From Pathologic Response to Response-Adapted Management.

Critical reviews in oncology/hematology·2026
Same journal

DNA polymerase epsilon catalytic subunit (POLE) in cancer: implications for tumor biology and therapeutic strategies - a comprehensive review.

Critical reviews in oncology/hematology·2026
Same journal

Long Non-Coding RNAs in Triple-Negative Breast Cancer: Emerging Drivers of Tumor Biology, Prognosis, and Drug Resistance.

Critical reviews in oncology/hematology·2026
Same journal

Alternative splicing in breast cancer drug resistance: Mechanisms, therapeutic targeting, and clinical translation.

Critical reviews in oncology/hematology·2026
Same journal

Gene Fusions in Non-small cell lung carcinoma (NSCLC): Expert Perspectives and Practical Considerations for routine testing.

Critical reviews in oncology/hematology·2026
Same journal

Opportunities and Challenges of Dihydrodiol dehydrogenase Expression in Hepatocellular carcinoma.

Critical reviews in oncology/hematology·2026
See all related articles

As the elderly population grows, cancer treatment needs new approaches. Brachytherapy, a radiotherapy type, offers effective tumor control while sparing healthy tissues in older patients.

Area of Science:

  • Geriatric oncology
  • Radiotherapy
  • Medical physics

Background:

  • Increasing elderly population presents unique challenges in cancer care.
  • Traditional cancer treatments may not be optimal for older adults.
  • Need for tailored treatment strategies considering age-related physiological changes.

Purpose of the Study:

  • Review literature on cancer treatment in the elderly.
  • Focus on the role of radiotherapy and brachytherapy.
  • Evaluate current medical community attitudes and identify patient subgroups benefiting from brachytherapy.

Main Methods:

  • Systematic literature review.
  • Analysis of studies on radiotherapy and brachytherapy in elderly cancer patients.
  • Evaluation of treatment outcomes and normal tissue sparing.

Related Experiment Videos

Main Results:

  • Brachytherapy is an effective radiotherapy modality for elderly cancer patients.
  • It allows for better sparing of normal tissues compared to conventional treatments.
  • Similar tumor control rates can be achieved.

Conclusions:

  • Brachytherapy is a viable and potentially superior treatment option for select elderly cancer patients.
  • Further research is needed to define optimal patient selection criteria.
  • Addresses the growing need for specialized geriatric oncology care.